Cargando…

Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays

The accurate measurement of serological response to SARS-CoV-2 vaccination is needed to correlate responses with effective protective immunity. The World Health Organization (WHO) has created an international standard to allow harmonization of immune response assessment to an arbitrary unit across d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuo, Ran, Charlton, Carmen, Plitt, Sabrina, Thompson, L. Alexa, Braun, Sheila, Day, Jacqueline, Osiowy, Carla, Tipples, Graham, Kanji, Jamil N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444336/ https://www.ncbi.nlm.nih.gov/pubmed/36108404 http://dx.doi.org/10.1016/j.jcv.2022.105292

Ejemplares similares

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies
por: Charlton, Carmen L., et al.
Publicado: (2020)

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
por: Kanji, Jamil N., et al.
Publicado: (2021)

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories
por: Stein, Derek R., et al.
Publicado: (2021)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2022)

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies
por: Hiebert, Joanne, et al.
Publicado: (2021)

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
por: Charlton, Carmen L., et al.
Publicado: (2021)

Recovery of spiked troponin I in four routine assays
por: Loh, Tze Ping, et al.
Publicado: (2016)

Optimal Cutoff Titers for Indirect Immunofluorescence Assay for Diagnosis of Scrub Typhus
por: Lim, Cherry, et al.
Publicado: (2015)

Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern
por: Pabbaraju, Kanti, et al.
Publicado: (2022)

Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers
por: Saker, Kahina, et al.
Publicado: (2022)

A low-cost initiative to reduce duplicate hepatitis B virus serological testing
por: Passi, Amrit, et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
por: Heaney, Christopher D., et al.
Publicado: (2021)

Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing
por: Zelyas, Nathan, et al.
Publicado: (2023)

Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types
por: Kanji, Jamil N, et al.
Publicado: (2021)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance
por: Zelyas, Nathan, et al.
Publicado: (2021)

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
por: Patel, Eshan U., et al.
Publicado: (2020)

Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
por: Patel, Eshan U., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
por: Valdivia, Arantxa, et al.
Publicado: (2021)

938. Identifying Gaps in the Treatment of Hepatitis C in Patients Co-Infected with HIV in Edmonton, Alberta
por: Savaryn, Bohdan, et al.
Publicado: (2020)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Determining procalcitonin at point-of-care; A method comparison study of four commercial PCT assays
por: Li, Chunbao, et al.
Publicado: (2021)

Horizontal Transmission of Hepatitis B Virus From Mother to Child Due to Immune Escape Despite Immunoprophylaxis
por: Kanji, Jamil N., et al.
Publicado: (2019)

Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID(50) Assays
por: Keiser, Patrick T., et al.
Publicado: (2021)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016)

Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron
por: Adachi, Eisuke, et al.
Publicado: (2022)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
por: Krüttgen, Alexander, et al.
Publicado: (2020)

Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study
por: Kanji, Jamil N., et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Development of a quick dot blot assay for the titering of bovine ephemeral fever virus
por: Cheng, Li-Ting, et al.
Publicado: (2019)

Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
por: Springer, David Niklas, et al.
Publicado: (2022)

POS-925 FACTORS PREDICTIVE OF ANTI-SPIKE ANTIBODIES TITERS AFTER COVID-19 VACCINATION IN HEMODIALYSIS PATIENTS
por: AOUN, M., et al.
Publicado: (2022)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff
por: Kanji, Jamil N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tk1ips805ddrnjhvdo3kldlos